Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources ; day:15 ; month:7 ; year:2016 ; pages:1-16
Rheumatology and therapy ; (15.7.2016), 1-16
- Urheber
-
Monemi, Sharareh
- Beteiligte Personen und Organisationen
-
Berber, Erhan
Sarsour, Khaled
Wang, Jianmei
Lampl, Kathy
Bharucha, Kamal
Pethoe-Schramm, Attila
SpringerLink (Online service)
- DOI
-
10.1007/s40744-016-0037-z
- URN
-
urn:nbn:de:1111-2016071924785
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Monemi, Sharareh
- Berber, Erhan
- Sarsour, Khaled
- Wang, Jianmei
- Lampl, Kathy
- Bharucha, Kamal
- Pethoe-Schramm, Attila
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Colonic carcinoma with multiple small bowel perforations mimicking intestinal obstruction
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Active immunization with Tocilizumab mimotopes induces specific immune responses
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Else Gabriel, Auto-Perforations-Artist
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Colonic carcinoma with multiple small bowel perforations mimicking intestinal obstruction
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Active immunization with Tocilizumab mimotopes induces specific immune responses
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Else Gabriel, Auto-Perforations-Artist
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Colonic carcinoma with multiple small bowel perforations mimicking intestinal obstruction
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Active immunization with Tocilizumab mimotopes induces specific immune responses
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic